Use of Chloroquine or Hydroxychloroquine
in Treatment of COVID-19: Is it Ethical?
Mohamed Farouk Allam, Fady
Andraous
Department of Family Medicine,
Faculty of Medicine, Ain Shams University, Cairo, Egypt
Central European Jounral of Public
Health 2020; 28 (3): 246-247
https://doi.org/10.21101/cejph.a6464
To date, the use of chloroquine or
hydroxychloroquine in COVID-19 treatment is restricted to clinical trials. The
efficacy of chloroquine or hydroxychloroquine in pre- or post-exposure
prophylaxis groups is unknown and pending the outcomes of clinical trials.
This raises the following
questions: is the current use of chloroquine or hydroxychloroquine, while
awaiting RCTs results, ethical? Should the medical community hold off its use
while the RCT results pend? Is it ethical to suggest the prophylactic use of
chloroquine or hydroxychloroquine for healthcare workers?
Keywords: Chloroquine, Hydroxychloroquine,
COVID-19, Clinical Trials, Ethics.
Central European Jounral of Public
Health 2020; 28 (3): 246-247
No hay comentarios:
Publicar un comentario
Nota: solo los miembros de este blog pueden publicar comentarios.